Ivermectin was originally developed in the 1970s to treat parasitic infections in animals, primarily heartworms in dogs and cattle. Its success led to research on its use in humans, ultimately leading to approval for treating certain parasitic worm infections like river blindness and elephantiasis in the 1980s. It's important to note that ivermectin is not an antiviral medication and is not approved for preventing or treating COVID-19.
- Approved for specific worm infections: Ivermectin effectively targets specific human parasitic worms like onchocerciasis (river blindness), lymphatic filariasis (elephantiasis), and strongyloidiasis.
- Off-label uses: Due to its broad-spectrum antiparasitic effects, research explores its potential for other conditions like scabies and intestinal parasites, but further studies and regulatory approval are needed.
- Not for COVID-19: Despite misinformation, ivermectin is not approved for preventing or treating COVID-19. In fact, using it for this purpose can be dangerous due to potentially severe side effects.
Comment